These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17196068)

  • 21. Occipital seizures and visual pseudohallucinations associated with the addition of bupropion to clozapine: a case report.
    Castelnovo A; Zambrelli E; Canevini MP; Cavallotti S; Scarone S; D'Agostino A
    J Clin Psychopharmacol; 2015 Feb; 35(1):97-9. PubMed ID: 25502485
    [No Abstract]   [Full Text] [Related]  

  • 22. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.
    Kito S; Koga Y
    Int Psychogeriatr; 2006 Dec; 18(4):749-51. PubMed ID: 17026779
    [No Abstract]   [Full Text] [Related]  

  • 23. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 24. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
    Yasui-Furukori N; Kaneko S
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probable Bupropion-Related QTc Prolongation in an Adolescent With Major Depressive Disorder.
    Naguy A; Alamiri B
    Am J Ther; 2020 Aug; 29(1):e124-e126. PubMed ID: 32769385
    [No Abstract]   [Full Text] [Related]  

  • 26. Bupropion response on sleep quality in patients with depression: implications for increased cardiovascular disease risk.
    Schramm PJ; Poland RE; Rao U
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):207-14. PubMed ID: 24239431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 28. Partial status epilepticus after electroconvulsive therapy and medical treatment with bupropion.
    Dersch R; Zwernemann S; Voderholzer U
    Pharmacopsychiatry; 2011 Nov; 44(7):344-6. PubMed ID: 21979924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bupropion and nightmares.
    Balon R
    Am J Psychiatry; 1996 Apr; 153(4):579-80. PubMed ID: 8599416
    [No Abstract]   [Full Text] [Related]  

  • 30. Bupropion-induced hypomania in a patient with unipolar depression.
    Hussain H; Butt MA
    Aust N Z J Psychiatry; 2008 Aug; 42(8):746. PubMed ID: 18622783
    [No Abstract]   [Full Text] [Related]  

  • 31. Can we recommend mirtazapine and bupropion for patients at risk for bleeding?: A systematic review and meta-analysis.
    Na KS; Jung HY; Cho SJ; Cho SE
    J Affect Disord; 2018 Jan; 225():221-226. PubMed ID: 28841484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Have we underestimated the possibility of bupropion sustained-release addiction?
    Hu LY; Lu T; Chen YT
    Aust N Z J Psychiatry; 2016 Sep; 50(9):925-6. PubMed ID: 26921279
    [No Abstract]   [Full Text] [Related]  

  • 33. Bupropion clarification.
    Kent RS
    J Clin Psychiatry; 1999 Mar; 60(3):196. PubMed ID: 10192599
    [No Abstract]   [Full Text] [Related]  

  • 34. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bupropion induced premature ejaculation.
    Evrensel A; Ceylan ME
    Turk Psikiyatri Derg; 2014; 25(4):290. PubMed ID: 25630067
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.
    Bech P; Fava M; Trivedi MH; Wisniewski SR; Rush AJ
    Acta Psychiatr Scand; 2012 Apr; 125(4):342-8. PubMed ID: 22077211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features.
    Seo HJ; Lee BC; Seok JH; Jeon HJ; Paik JW; Kim W; Kwak KP; Han C; Lee KU; Pae CU
    Pharmacopsychiatry; 2013 Sep; 46(6):221-6. PubMed ID: 23963965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seizure during combination of trimipramine and bupropion.
    Enns MW
    J Clin Psychiatry; 2001 Jun; 62(6):476-7. PubMed ID: 11465529
    [No Abstract]   [Full Text] [Related]  

  • 39. Bupropion and breastfeeding: a case of a possible infant seizure.
    Chaudron LH; Schoenecker CJ
    J Clin Psychiatry; 2004 Jun; 65(6):881-2. PubMed ID: 15291673
    [No Abstract]   [Full Text] [Related]  

  • 40. Bupropion-induced psychosis.
    Howard WT; Warnock JK
    Am J Psychiatry; 1999 Dec; 156(12):2017-8. PubMed ID: 10588428
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.